Inovio Pharmaceuticals, Inc.
Vaccines with CD40 ligand as an adjuvant
Last updated:
Abstract:
Disclosed herein is a vaccine comprising an antigen and CD40L. Also disclosed herein are methods for increasing an immune response in a subject. The methods may comprise administering the vaccine to the subject in need thereof.
Status:
Grant
Type:
Utility
Filling date:
18 Mar 2016
Issue date:
23 Feb 2021